We are live on
!
Find out more
DGM
Darwin Global Management Portfolio holdings
AUM
$3.77B
1-Year Est. Return
307.72%
This Fund
S&P 500
This Quarter
Est. Return
-0.41%
1 Year Est. Return
+307.72%
3 Year Est. Return
+2,873.14%
5 Year Est. Return
+48,315.58%
10 Year Est. Return
–
AUM
$188M
AUM Growth
+$78M
(+71%)
Cap. Flow
+$77.9M
Cap. Flow
% of AUM
41.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$77.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
VVP
ABC
SCA
ACH
GL
VA
GCC
SB
Darwin Global Management's Q2 2022 Portfolio in Review
As of Q2 2022, Darwin Global Management held 1 position worth $188M, up 71% from $110M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Darwin Global Management deployed $77.9M of net new capital in Q2 2022, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Darwin Global Management added most to AstraZeneca in Q2 2022, an estimated $77.9M increase.
- Darwin Global Management's ten largest holdings make up 100% of its $188M portfolio in Q2 2022.
- Darwin Global Management opened 0 new positions and closed 0 in Q2 2022.
- Darwin Global Management's portfolio value rose 71% quarter-over-quarter to $188M.
Based on Darwin Global Management's 13F filing for Q2 2022, filed 15 Aug 2022.